The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB
Authors:
- Yukari OkitaYOYukari Okita
- Minori KimuraMKMinori Kimura
- Rudy XieRXRudy Xie
- Chen ChenCCChen Chen
- Larina Tzu-Wei ShenLSLarina Tzu-Wei Shen
- Hiroyuki SuzukiHSHiroyuki Suzuki
- Masafumi MurataniMMMasafumi Muratani
- Masao SaitohMSMasao Saitoh
- Kentaro SembaKSKentaro Semba
- Carl-Henrik HeldinCHCarl-Henrik Heldin
- Mitsuyasu KatoMKMitsuyasu Kato
- 11 April 2017
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 10 (474)
Abstract
Triple-negative breast cancer (TNBC) is particularly aggressive and difficult to treat. For example, the transforming growth factor–β (TGF-β) pathway is implicated in TNBC progression and metastasis, but its opposing role in tumor suppression in healthy tissues and early-stage lesions makes it a challenging target. Therefore, additional molecular characterization of TNBC may lead to improved patient prognosis by informing the development and optimum use of targeted therapies. We found that musculoaponeurotic fibrosarcoma (MAF) oncogene family protein K (MAFK), a member of the small MAF family of transcription factors that are induced by the TGF-β pathway, was abundant in human TNBC and aggressive mouse mammary tumor cell lines. MAFK promoted tumorigenic growth and metastasis by 4T1 cells when implanted subcutaneously in mice. Overexpression of MAFK in mouse breast epithelial NMuMG cells induced epithelial-mesenchymal transition (EMT) phenotypes and promoted tumor formation and invasion in mice. MAFK induced the expression of the gene encoding the transmembrane glycoprotein nmb (GPNMB). Similar to MAFK, GPNMB overexpression in NMuMG cells induced EMT, tumor formation, and invasion, in mice, whereas knockdown of MAFK in tumor cells before implantation suppressed tumor growth and progression. MAFK and GPNMB expression correlated with poor prognosis in TNBC patients. These findings suggest that MAFK and its target gene GPNMB play important roles in the malignant progression of TNBC cells, offering potentially new therapeutic targets for TNBC patients.Keywords
Funding Information
- Swedish Research Council for Health, Working Life and Welfare (award296592)
This publication has 62 references indexed in Scilit:
- Small Maf proteins (MafF, MafG, MafK): History, structure and functionGene, 2016
- Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular linksSeminars in Cancer Biology, 2012
- Embryonic Lethality and Fetal Liver Apoptosis in Mice Lacking All Three Small Maf ProteinsMolecular and Cellular Biology, 2012
- Molecular classification of breast carcinomas with particular emphasis on “basal‐like” carcinoma: A critical reviewJournal of Biophotonics, 2012
- Tumor Metastasis: Molecular Insights and Evolving ParadigmsCell, 2011
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- Gene expression profiling of breast cell lines identifies potential new basal markersOncogene, 2005